MTVA: Phase 1 Part 2 Data for DA-1726 in Obesity Expected Soon…
MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Data Expected in April 2025 from Part 2 of Phase 1 Trial of DA-1726 ...
pharmaphorum23h
Positive phase 3 results for Zealand Pharma's glepaglutide
Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with ...
Reuters23h
Healthcare & Pharmaceuticals
A Johnson & Johnson banner is displayed on the front of the New York Stock Exchange (NYSE) in New York City, in New York City, U.S., December 5, 2023. REUTERS/Brendan McDermid/File Photo A federal ...
Finanzen10023h
Eli Lilly & Co Aktie
Xtrackers S&P 500 Swap UCITS ETF - 1C USD ACC 23% SPDR S&P 500 UCITS ETF - USD DIS 23% ...